Prolonged therapy with the fusion inhibitor T-20 in combination with oral antiretroviral agents in an HIV-infected individual.
Pilcher
C D
CD
Eron
J J
JJ
Ngo
L
L
Dusek
A
A
Sista
P
P
Gleavy
J
J
Brooks
D
D
Venetta
T
T
DiMassimo
E
E
Hopkins
S
S
D000284:Administration, Oral; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D015700:HIV Envelope Protein gp41 / Q000737:chemistry*; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors; D006801:Humans; D008297:Male; D008875:Middle Aged; D019888:Nelfinavir; D019829:Nevirapine; D010455:Peptides / Q000737:chemistry* / Q000627:therapeutic use*; D018894:Reverse Transcriptase Inhibitors; D019258:Saquinavir
D019380:Anti-HIV Agents; D015700:HIV Envelope Protein gp41; D017320:HIV Protease Inhibitors; D010455:Peptides; D018894:Reverse Transcriptase Inhibitors; D019829:Nevirapine; D019888:Nelfinavir; D019258:Saquinavir